Testing effectiveness (Phase 2)Ended earlyNCT00915811
What this trial is testing
Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin
Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, Acute
King's College Hospital NHS Trust 20